We believe that local production capability for Canada is very important. When we get into situations with dose allocations, I anticipate that having local production capability in Canada is going to be important for the people in Canada.
I also will make a point that as a company based in Canada that also operates globally, we have a production facility and employees based in the U.S., and the current shareholders are actually in Asian and European countries. Also, the virus has no national boundary. In a way, this is a global business and we have to make sure that we are not handicapped by vaccine nationalism as we try to run the business.